,

Paediatric Melatonin: Sleep Support for Children on the Autism Spectrum

  • A prolonged-release paediatric melatonin formulation mimics the body’s natural overnight melatonin secretion, supporting both sleep onset and sleep maintenance.
  • Clinical trials have proven that prolonged-release paediatric melatonin specifically tested for children helps children fall asleep faster than placebo.
  • Studies on prolonged-release paediatric melatonin demonstrated increased total sleep time and reduces night-time awakenings, promoting longer periods of uninterrupted sleep.
  • Improved sleep has been associated with better daytime behaviour, attention and emotional regulation.
  • Caregivers report improved quality of life and reduced stress when children’s sleep improves with prolonged-release paediatric melatonin where long-term studies of up to two years have demonstrated sustained efficacy with reassuring safety data.
  • Unlike compounded melatonin, a prolonged released paediatric melatonin offers consistent dosing, manufacturing quality and release characteristics.
  • A prolonged-release paediatric melatonin should be considered after appropriate sleep hygiene and behavioural interventions have been implemented and in consultation with a healthcare professional.
/by